Charles Bennett to ADAMTS13 Protein
This is a "connection" page, showing publications Charles Bennett has written about ADAMTS13 Protein.
Connection Strength
0.656
-
Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions. Transfusion. 2017 08; 57(8):2045-2053.
Score: 0.140
-
Thrombotic thrombocytopenic purpura: gaining knowledge. Lancet Haematol. 2016 05; 3(5):e210-1.
Score: 0.130
-
Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR). Br J Haematol. 2013 Jun; 161(6):896-8.
Score: 0.105
-
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl. 2009 Feb; (112):S20-4.
Score: 0.079
-
Thrombotic thrombocytopenic purpura-2005. Semin Thromb Hemost. 2005 Dec; 31(6):611-4.
Score: 0.063
-
Drug-induced thrombotic microangiopathy. Semin Thromb Hemost. 2005 Dec; 31(6):681-90.
Score: 0.063
-
Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma. Transfusion. 2015 Oct; 55(10):2321-30.
Score: 0.031
-
Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from Japan. PLoS One. 2012; 7(3):e33029.
Score: 0.024
-
Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica. 2010 Sep; 95(9):1555-62.
Score: 0.021